The European medical device sector is witnessing an exciting phase of innovation and advancements. In this article, we present five ground-breaking European medical device start-ups poised to impact the healthcare sector by 2024 significantly.
Parasym Health, a UK-based start-up, offers innovative neurostimulation products for individuals suffering from inflammatory disorders and chronic pain. Using electrical micro pulses, their first product targets the vagus nerve through an ear clip electrode. With encouraging results from their 2022 clinical trial and big plans for 2024, Parasym Health is one to watch.
InVivo Bionics, a Norwegian medical device company, utilised Qualio's expertise to build its quality management system from scratch. Focusing on creating state-of-the-art medical devices and targeting the European market, InVivo Bionics is set to significantly impact healthcare solutions in the coming years.
Flow Neuroscience, a Swedish medical device company, is revolutionising depression treatment with its innovative Flow headset. Using transcranial direct current stimulation (tDCS), the therapy shows promise in addressing depression without medication or side effects. With 83% of users reporting results within the first three weeks, Flow Neuroscience is poised to transform the mental health landscape.
Based in Switzerland, Hemotune is working on magnetic blood purification technology that can potentially change how blood treatments are performed. Their innovative "hemosystem" seeks to tackle septic shock, infections, and autoimmune diseases. With its promise to revolutionise healthcare, Hemotune is a company to watch closely.
Senzo, a UK-based start-up, is making waves with its amplified lateral flow (ALF) rapid antigen self-test for COVID-19, which boasts 100% accuracy. With plans to apply their ALF system to other testing requirements, Senzo aims to bring laboratory-grade self-testing to people worldwide. Despite COVID-19 potentially being a problem of the past in 2024, Senzo is forward-looking and plans to tackle other prevalent and deadly diseases. Their recent Pre-Series A funding round focuses on increasing manufacturing capabilities and advancing the diagnosis of the world's most challenging health issues.
These European medical device start-ups are trailblazers in their respective fields, poised to impact the healthcare sector by 2024 significantly. Their innovative approaches focus on quality and commitment to finding solutions for pressing health challenges, making them companies to watch as they evolve and develop closely.
Comments